[
  {
    "ts": null,
    "headline": "AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk",
    "summary": "AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=97963aec81445ff676b23871bfef68c04faaac987c94a9cb5d5b71726d72c61d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741881328,
      "headline": "AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk",
      "id": 133164007,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/487502156/image_487502156.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=97963aec81445ff676b23871bfef68c04faaac987c94a9cb5d5b71726d72c61d"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=05438e065727cdd655e5e711ea1f98a880618bccc6ba7e5d5c89b90db1e7d73f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741870818,
      "headline": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
      "id": 133184485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=05438e065727cdd655e5e711ea1f98a880618bccc6ba7e5d5c89b90db1e7d73f"
    }
  },
  {
    "ts": null,
    "headline": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
    "summary": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
    "url": "https://finnhub.io/api/news?id=162bce9bf0ba88f9c79473aefed174c1c9a8e586a46d3ad30bf105dc968135a7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741829400,
      "headline": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
      "id": 134146991,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
      "url": "https://finnhub.io/api/news?id=162bce9bf0ba88f9c79473aefed174c1c9a8e586a46d3ad30bf105dc968135a7"
    }
  }
]